Monday, November 25, 2024
HomeTagsHPV-driven Head

HPV-driven Head

Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-driven Head and Neck Cancer with NavDx in DART 2.0 Clinical Trial

Naveris, Inc., a leader in molecular diagnostics for viral cancers, announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic. The...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics